Sponsored by Pfizer

Articles by Sponsored by Pfizer

A Changing Treatment Landscape for Patients with Relapsed/Refractory Diffuse Large B-Cell Lymphoma

BySponsored by Pfizer

December 4th 2025

Sponsored Content

Bispecific antibodies in multiple myeloma: revolutionizing blood cancer immunotherapy

ByDr. Jeff Settleman, Ph.D., Chief Scientific Officer, Oncology Research and Development, Pfizer ,Sponsored by Pfizer

June 21st 2024

Bridging Gaps, Expanding Outreach: Identifying the Unmet Needs of Women Living with Metastatic Breast Cancer

BySponsored by Pfizer

September 19th 2008

The purpose of this Priority Report is to raise awareness of metastatic breast cancer.

Latest Updated Articles

Bispecific antibodies in multiple myeloma: revolutionizing blood cancer immunotherapy
June 21st 2024
Bridging Gaps, Expanding Outreach: Identifying the Unmet Needs of Women Living with Metastatic Breast Cancer
September 19th 2008

Trending on OncLive

RELATIVITY-1093 Trial Aims to Advance Nivolumab Plus Relatlimab and Chemo in Nonsquamous NSCLC

Dostarlimab Monotherapy Elicits Durable cCRs in dMMR/MSI-H Locally Advanced Rectal Cancer

NEXERA-303 Trial Aims to Bring TGFβR2×PD-1 Bispecific Antibody INCA33890 Into First-Line MSS CRC

The OncFive: Top Oncology Articles for the Week of 10/25

Dr Gatti on the Prognostic Impact of ESR1 Mutations and Co-Alterations in Breast Cancer